Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
Jacob Small Cap Growth Institutional JSIGX
- NAV / 1-Day Return 19.48 / +1.19 %
- Total Assets 6.9 Mil
-
Adj. Expense Ratio
- Expense Ratio 2.830%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 100,000
- Status Open
- TTM Yield 0.00
- Turnover 64%
USD | NAV as of Oct 02, 2024 | 1-Day Return as of Oct 02, 2024, 10:25 PM GMT+0
Morningstar’s Analysis JSIGX
Will JSIGX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 49.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Harrow Inc | 6.73 | 457,783 | Healthcare |
Inspired Entertainment Inc | 5.32 | 362,267 | Consumer Cyclical |
Cantaloupe Inc | 5.00 | 340,355 | Technology |
CareDx Inc | 4.86 | 331,053 | Healthcare |
Doximity Inc Class A | 4.85 | 330,046 | Healthcare |
Heron Therapeutics Inc | 4.65 | 316,740 | Healthcare |
Alphatec Holdings Inc | 4.62 | 314,158 | Healthcare |
Esperion Therapeutics Inc | 4.47 | 304,140 | Healthcare |
Thunderbird Entertainment Group Inc | 4.36 | 296,700 | Communication Services |
OptimizeRx Corp | 4.35 | 296,350 | Healthcare |